Treatment with masitinib led to lower blood levels of neurofilament light chain (NfL) and pro-inflammatory signaling ...

The signaling molecule IL-6, involved in inflammation, is associated with increasing frailty in relapsing-remitting MS, a ...

While his multiple sclerosis is a big part of columnist Ben Hofmeistser's life, it's not his only health concern that deserves attention.

Three months of supplements with ellagic acid — an antioxidant — significantly eased fatigue, depression, and anxiety in MS ...

Non-pharmacological interventions, such as mindfulness and exercise, may improve sleep for MS patients, a meta-analysis of ...

Upon receiving her master's degree, columnist Desiree Lama reflects on how her parents have supported her while she's living ...

RRMS patients started on high-efficacy treatments may have less reduction in work capacity than those on moderate-efficacy DMTs, per a study.

The PoNS device has shown significant benefits in walking and balance in clinical trials, and benefits were seen in ...